VEGF-A and the Induction of Pathological Angiogenesis

Annual Review of Pathology: Mechanisms of Disease - Tập 2 Số 1 - Trang 251-275 - 2007
Janice A. Nagy1, Ann M. Dvořàk2, Harold F. Dvorak2
1Department of Pathology and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. [email protected]
2Department of Pathology and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215

Tóm tắt

Tumors, wounds, and chronic inflammatory disorders generate a new vascular supply by a process known as pathological angiogenesis. Whereas formation of the normal blood vasculature requires the interaction of many different agonists and inhibitors, including vascular endothelial growth factor-A (VEGF-A) and other members of the vascular permeability factor/VEGF family, pathological angiogenesis is a cruder, simpler process that can be replicated by a single VEGF-A isoform, VEGF-A164/5. VEGF-A164/5induces the formation of several distinctly different types of new blood vessels that differ from normal blood vessels with respect to organization, structure, and function. Elucidating the properties of these new vessels has led to a better understanding of angiogenesis and will hopefully lead to new approaches to antiangiogenic therapy.

Từ khóa


Tài liệu tham khảo

10.1096/fasebj.11.5.9141503

10.1038/35025215

10.1016/S0092-8674(00)81810-3

10.1038/74651

10.1016/j.yexcr.2005.09.002

10.1016/j.yexcr.2005.10.028

10.1016/j.yexcr.2005.10.019

10.1111/j.1582-4934.2002.tb00307.x

10.1101/sqb.2002.67.227

10.1016/S0002-9440(10)64309-X

10.1017/CBO9780511546198.159

10.1038/labinvest.3700436

10.1200/JCO.2002.10.088

10.1161/01.CIR.104.1.115

10.1016/j.yjmcc.2003.10.002

10.1016/j.cardiores.2004.11.020

10.1038/labinvest.3780013

10.1016/S0002-9440(10)64062-X

10.1152/physrev.00005.2002

10.1038/nm0603-669

Carmeliet P, 1999, Curr. Top Microbiol. Immunol., 237, 133

Dvorak HF, 1979, J. Immunol., 122, 166, 10.4049/jimmunol.122.1.166

10.1126/science.6823562

Dvorak H. 2006. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF, VEGF-A). InMicrovascular Research, Vol. 1, ed. D Shepro, pp.97–103. Boston: Elsevier

10.1002/(SICI)1097-4652(199711)173:2<211::AID-JCP23>3.0.CO;2-H

10.1016/j.pupt.2005.02.007

10.1146/annurev.cellbio.21.012704.132338

10.1038/87904

10.1016/S1050-1738(02)00168-8

10.1038/nrm1911

10.1016/j.canlet.2004.12.047

Brown LF, 1997, EXS, 79, 233

10.1111/1523-1747.ep12286453

10.1038/nrc925

10.2174/156800905774574020

10.1172/JCI17189

10.1016/j.ajog.2005.10.192

10.1016/j.yexcr.2005.11.024

10.1016/j.conb.2005.01.008

10.1016/j.yexcr.2005.11.009

10.1073/pnas.94.14.7192

10.1038/380435a0

10.1038/380439a0

10.1158/0008-5472.CAN-04-0934

10.1128/MCB.20.19.7282-7291.2000

10.1016/S0925-4773(01)00601-3

10.1091/mbc.4.12.1317

Yu JL, 2002, Canc. Res., 62, 1838

10.1002/bies.10351

10.1210/edrv-13-1-18

10.1038/nm0603-653

10.2353/ajpath.2006.050372

10.1038/35036374

10.1083/jcb.200409115

Brown LF, 1995, J. Immunol., 154, 2801, 10.4049/jimmunol.154.6.2801

10.1091/mbc.3.2.211

10.2353/ajpath.2006.050834

10.1210/endo-127-2-965

Kamat BR, 1995, Am. J. Pathol., 146, 157

10.1038/9467

10.1016/S0092-8674(00)81731-6

10.1007/s004280000327

10.1016/j.leukres.2003.08.001

Yasui H, 2006, Br. J. Haematol., 132, 385, 10.1111/j.1365-2141.2005.05860.x

Brown LF, 1996, Am. J. Pathol., 148, 1065

10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y

10.1093/jnci/87.16.1237

10.1016/j.humpath.2005.07.015

Harrison-Woolrych M, 1995, J. Clin. Endocrinol. Metab., 80, 1853

10.1007/BF00437469

10.1038/ki.1997.82

Fukumura D, 2001, Canc. Res., 61, 6020

10.1016/j.semcancer.2003.09.014

10.1016/j.semcancer.2003.09.019

10.1017/CBO9780511546198.033

10.2741/1839

10.1016/j.yexcr.2005.11.012

10.1073/pnas.0403198102

10.1073/pnas.041359198

10.1073/pnas.94.16.8761

10.1006/excr.1997.3583

Mukhopadhyay D, 1998, Canc. Res., 58, 1278

10.1161/01.ATV.17.11.2793

10.1006/mvre.1999.2225

10.1152/ajpheart.2001.280.1.H434

10.1084/jem.20051523

10.1111/j.1538-7836.2005.01361.x

10.1016/S1050-1738(03)00056-2

Kohn S, 1992, Lab. Invest., 67, 596

10.1084/jem.183.5.1981

10.1002/jlb.59.1.100

Nagy JA, 1995, Canc. Res., 55, 376

10.1177/002215540205000108

10.1007/s004410051121

10.1073/pnas.96.23.13203

Roberts WG, 1997, Canc. Res., 57, 765

10.1111/j.1469-7793.1997.747bd.x

10.1006/mvre.1999.2207

10.1080/713773925

10.1083/jcb.42.3.647

10.1113/jphysiol.1995.sp020977

10.1080/713773926

10.1080/713773924

10.1056/NEJMoa032691

Nagy JA, 1995, Canc. Res., 55, 369

Gullino P, 1975, Cancer: A Comprehensive Treatise, 327

10.1016/j.ophtha.2005.11.019

Dvorak HF, 2006, Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 851

10.3109/10739689709148314

10.1084/jem.176.5.1375

Li J, 1996, Am. J. Physiol., 270, H1803

Stowe AM, 2006, J. Cereb. Blood Flow Metab.

10.1084/jem.180.3.1141

10.1084/jem.180.1.341

10.1172/JCI5028

10.1038/sj.onc.1201033

10.1152/ajpheart.00616.2005

Straume O, 2002, Canc. Res., 62, 6808

10.1084/jem.20021244